---
title: The Influence of Voxelotor on Cerebral Blood Flow and Oxygen Extraction in
  Pediatric Sickle Cell Disease
date: '2024-02-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38364110/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240217170634&v=2.18.0
source: Blood
description: Voxelotor is an inhibitor of sickle hemoglobin polymerization that is
  used to treat sickle cell disease. While voxelotor has been shown to improve anemia,
  the clinical benefit on the brain remains to be determined. This study quantified
  the cerebral hemodynamic effects of voxelotor in children with sickle cell anemia
  (SCA) using non-invasive diffuse optical spectroscopies. Specifically, frequency-domain
  near-infrared spectroscopy (FDNIRS) combined with diffuse correlation spectroscopy
  (DCS) ...
disable_comments: true
---
Voxelotor is an inhibitor of sickle hemoglobin polymerization that is used to treat sickle cell disease. While voxelotor has been shown to improve anemia, the clinical benefit on the brain remains to be determined. This study quantified the cerebral hemodynamic effects of voxelotor in children with sickle cell anemia (SCA) using non-invasive diffuse optical spectroscopies. Specifically, frequency-domain near-infrared spectroscopy (FDNIRS) combined with diffuse correlation spectroscopy (DCS) ...